Ypeginterferon Alfa-2a

pegylated interferon alfa-2a · Xiamen Amoytop Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ypeginterferon Alfa-2a, covering 2012-01-31 to 2012-01-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Assessment of Ypeginterferon Alfa-2a in Healthy Subjects [Phase 1]

See pricing